title: ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.
authors.affiliation: Laboratory of Hematopathology and Immunology, National Hematology Hospital , Sofia , Bulgaria.
authors.forename: Velizar
authors.initials: V
authors.lastname: Shivarov
authors.forename: Ralitza
authors.initials: R
authors.lastname: Gueorguieva
authors.forename: Milena
authors.initials: M
authors.lastname: Ivanova
authors.forename: Ramon V
authors.initials: RV
authors.lastname: Tiu
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020869:Gene Expression Profiling; D015973:Gene Expression Regulation, Leukemic; D005787:Gene Frequency; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011379:Prognosis; D012097:Repressor Proteins / Q000235:genetics*; D055815:Young Adult
chemical_list: C473949:ASXL1 protein, human; D012097:Repressor Proteins